Summit Therapeutics Inc —— 季度财务数据 (NASDAQ:SMMT) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 -48.67 M-61.17 M-66.74 M-93.08 M-101.94 M -322.93 M 投资活动产生的现金 83.48 M160.11 M150.81 M-71 K-485.16 M -174.31 M 融资活动产生的现金 -23.61 M7.68 M2.22 M33.81 M573.82 M 617.53 M 自由现金流 -48.69 M-61.59 M-66.74 M-93.15 M-102.1 M -323.59 M

新闻

Why Is Ironwood (IRWD) Down 13.9% Since Last Earnings Report?

Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)

Jefferies因试验风险下调Summit Therapeutics股票评级

Jefferies downgrades Summit Therapeutics stock rating on trial risks

Micron and Facebook among market cap stock movers on Friday

Summit Therapeutics在Citizens生命科学会议上的演讲:伊伏西单抗战略见解

Summit Therapeutics at The Citizens Life Sciences Conference: Strategic Insights on Ivonescimab

Summit Therapeutics Inc. (SMMT) Presents at The Citizens Life Sciences Conference 2026 Transcript

东方证券：创新药板块短期波动仍有可能延续建议积极关注低位布局投资机会

Summit Therapeutics在TD Cowen会议上聚焦Ivonesimab战略布局

Summit Therapeutics at TD Cowen Conference: Strategic Focus on Ivonesimab

RVMD Reports Wider-Than-Expected Q4 Loss, Issues 2026 Expense View